Turning Cancer Patients and Caregivers Into Informed Decision- Makers 


Hi, my name is David Emerson, and I have been living with an incurable cancer called Multiple Myeloma since 1994. I started PeopleBeatingCancer.org because I believe that there is a problem with cancer care today.  Cancer patients and caregivers are asked to make huge decisions about their health-- often while woefully uninformed, and under an extreme time crunch. How many of you are here because you were given 24 hours to approve your chemotherapy regimen? 

Let me be clear: knowledge is power. The more you know, the better decisions you'll make for your care.  Yes, I said YOU. You are in control. This website and the non-profit organization that supports it are dedicated to helping cancer survivors and caregivers become informed, educated decision-makers about their treatment. All information found on this site is evidence-based with the studies cited, and actionable-- you can get started using the protocols right away.


Check out our latest blog posts:

Got Androgen Deprivation Therapy? (ADT)-Get Nutritional Supplementation-
This review summarizes pre-clinical and clinical studies investigating the ability of dietary supplements to alleviate adverse effects arising from Androgen[...]
Multiple Myeloma- Oral Enzymes as Integrative Therapy for Deeper, Longer Remissions
Oral Enzymes for multiple myeloma result in "significantly higher overall response rates and longer duration of remissions" If you have[...]
Androgen Deprivation Therapy Slows Prostate Cancer but Causes Heart Disease
Heart Disease, Not Cancer, The Leading Cause Of Death Among Prostate Cancer (PCa) Survivors My understanding is that in order[...]
Anti-Angiogenis for Disease-free Survival in Melanoma
Evidence suggests that β-blockers may have anti-tumorigenic properties, and previous studies demonstrated that propranolol in particular may inhibit angiogenesis and[...]
Managing Brain Damage in Head/Neck Cancer
In a pilot study of the association, Razak and colleagues found that nine of 10 survivors of head/neck cancer had[...]
Monoclonal Gammopathy of Undetermined Significance (MGUS) Non-toxic Therapies
MGUS is an asymptomatic blood disorder estimated to affect more than 3% of Caucasians over the age of 50 and more than[...]